| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |